id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-202687-z17knvts	Angelina, Emilio	Drug Repurposing to find Inhibitors of SARS-CoV-2 Main Protease	2020-06-26		.txt	text/plain	4110	214	53	[11] In another study, Jin and colleagues identified a mechanism-based inhibitor, N3, by computer-aided drug design and subsequently determined the crystal structure of SARS-CoV-2 M pro in complex with this compound. Moreover, another recent crystallographic fragment screening against SARS-CoV-2 M pro that has been deposited in the Protein Data Bank (DOI: 10.2210/pdb5rgj/pdb ) also might help to find structural determinants for ligand anchoring within the enzyme binding cleft. Up to date, more than 100 structures of SARS-CoV-2 M pro with ligands bound at the enzyme binding cleft, have been released. While different fragments bind to different regions of SARS-CoV-2 M pro binding cleft, there are two interaction sites at the enzyme S1 sub-pocket that are targeted by most fragments. In this work we have performed a virtual screening of FDA approved drugs for repurposing as potential inhibitors of SARS-CoV-2 main protease M pro .	./cache/cord-202687-z17knvts.txt	./txt/cord-202687-z17knvts.txt